Younesian S, Mohammadi M, Younesian O, Momeny M, Ghaffari S, Bashash D
Heliyon. 2024; 10(11):e32366.
PMID: 38933971
PMC: 11200359.
DOI: 10.1016/j.heliyon.2024.e32366.
Wang Z, Cassidy M, Wallace D, Sofer T
Bioinformatics. 2024; 40(7).
PMID: 38897661
PMC: 11219476.
DOI: 10.1093/bioinformatics/btae410.
Ferro Dos Santos M, Giuili E, De Koker A, Everaert C, De Preter K
Brief Bioinform. 2024; 25(3).
PMID: 38762790
PMC: 11102637.
DOI: 10.1093/bib/bbae234.
Hannon E, Dempster E, Davies J, Chioza B, Blake G, Burrage J
BMC Biol. 2024; 22(1):17.
PMID: 38273288
PMC: 10809680.
DOI: 10.1186/s12915-024-01827-y.
Kim K, Kim H, Shin I, Noh S, Kim J, Suh K
Sci Rep. 2023; 13(1):22482.
PMID: 38110532
PMC: 10728099.
DOI: 10.1038/s41598-023-49639-4.
EpiMix is an integrative tool for epigenomic subtyping using DNA methylation.
Zheng Y, Jun J, Brennan K, Gevaert O
Cell Rep Methods. 2023; 3(7):100515.
PMID: 37533639
PMC: 10391348.
DOI: 10.1016/j.crmeth.2023.100515.
An overview of DNA methylation-derived trait score methods and applications.
Nabais M, Gadd D, Hannon E, Mill J, McRae A, Wray N
Genome Biol. 2023; 24(1):28.
PMID: 36797751
PMC: 9936670.
DOI: 10.1186/s13059-023-02855-7.
EpiMix: an integrative tool for epigenomic subtyping using DNA methylation.
Zheng Y, Jun J, Brennan K, Gevaert O
bioRxiv. 2023; .
PMID: 36711917
PMC: 9881910.
DOI: 10.1101/2023.01.03.522660.
Uncertainty quantification of reference-based cellular deconvolution algorithms.
Vellame D, Shireby G, MacCalman A, Dempster E, Burrage J, Gorrie-Stone T
Epigenetics. 2022; 18(1):2137659.
PMID: 36539387
PMC: 9980651.
DOI: 10.1080/15592294.2022.2137659.
Biophysics is reshaping our perception of the epigenome: from DNA-level to high-throughput studies.
Kanapeckaite A, Burokiene N, Mazeikiene A, Cottrell G, Widera D
Biophys Rep (N Y). 2022; 1(2):100028.
PMID: 36425454
PMC: 9680810.
DOI: 10.1016/j.bpr.2021.100028.
Tracing the Origin of Cell-Free DNA Molecules through Tissue-Specific Epigenetic Signatures.
Oberhofer A, Bronkhorst A, Uhlig C, Ungerer V, Holdenrieder S
Diagnostics (Basel). 2022; 12(8).
PMID: 36010184
PMC: 9406971.
DOI: 10.3390/diagnostics12081834.
Deconvolution of tumor composition using partially available DNA methylation data.
He D, Chen M, Wang W, Song C, Qin Y
BMC Bioinformatics. 2022; 23(1):355.
PMID: 36002797
PMC: 9400327.
DOI: 10.1186/s12859-022-04893-7.
Sparse principal component analysis based on genome network for correcting cell type heterogeneity in epigenome-wide association studies.
Miao R, Dang Q, Cai J, Huang H, Xie S, Liang Y
Med Biol Eng Comput. 2022; 60(9):2601-2618.
PMID: 35789457
DOI: 10.1007/s11517-022-02599-9.
Using R for Cell-Type Composition Imputation in Epigenome-Wide Association Studies.
Wu C
Methods Mol Biol. 2022; 2432:49-56.
PMID: 35505206
DOI: 10.1007/978-1-0716-1994-0_4.
Reliability of a novel approach for reference-based cell type estimation in human placental DNA methylation studies.
Dieckmann L, Cruceanu C, Lahti-Pulkkinen M, Lahti J, Kvist T, Laivuori H
Cell Mol Life Sci. 2022; 79(2):115.
PMID: 35113241
PMC: 8813756.
DOI: 10.1007/s00018-021-04091-3.
Computational challenges in detection of cancer using cell-free DNA methylation.
Sharma M, Verma R, Kumar S, Kumar V
Comput Struct Biotechnol J. 2022; 20:26-39.
PMID: 34976309
PMC: 8669313.
DOI: 10.1016/j.csbj.2021.12.001.
Epigenome-wide association studies: current knowledge, strategies and recommendations.
Campagna M, Xavier A, Lechner-Scott J, Maltby V, Scott R, Butzkueven H
Clin Epigenetics. 2021; 13(1):214.
PMID: 34863305
PMC: 8645110.
DOI: 10.1186/s13148-021-01200-8.
DNA methylation as a mediator of associations between the environment and chronic diseases: A scoping review on application of mediation analysis.
Fujii R, Sato S, Tsuboi Y, Cardenas A, Suzuki K
Epigenetics. 2021; 17(7):759-785.
PMID: 34384035
PMC: 9336467.
DOI: 10.1080/15592294.2021.1959736.
A Novel Computational Framework to Predict Disease-Related Copy Number Variations by Integrating Multiple Data Sources.
Yuan L, Sun T, Zhao J, Shen Z
Front Genet. 2021; 12:696956.
PMID: 34267783
PMC: 8276077.
DOI: 10.3389/fgene.2021.696956.
NLRC5: A Potential Target for Central Nervous System Disorders.
Zhang L, Jiao C, Liu L, Wang A, Tang L, Ren Y
Front Immunol. 2021; 12:704989.
PMID: 34220868
PMC: 8250149.
DOI: 10.3389/fimmu.2021.704989.